ArticleComputational and structural biotechnology journal2025
Histolytics: A panoptic spatial analysis framework for interpretable histopathology.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- PatternExtract: A Facile, Scalable Pipeline for Point Pattern Generation from Spatial Imaging Data.Computational and structural biotechnology journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quantifying spatial organization in hematoxylin and eosin (H&E)-stained whole-slide images (WSIs) is essential for uncovering tissue-level patterns relevant to pathology. We present Histolytics, an open-source, scalable Python framework for interpretable, WSI-scale histopathological analysis. Histolytics integrates panoptic segmentation with spatial querying, morphological profiling, and graph-based analytics to enable high-resolution, quantitative characterization of nuclei, tissue compartments, and the extracellular matrix (ECM). Designed to align with diagnostic reasoning, Histolytics supports segmentation with state-of-the-art deep learning models and provides modular tools for extracting biologically grounded features across entire WSIs. By leveraging spatially contextualized measurements at cellular and tissue levels, Histolytics addresses a critical gap in explainable computational pathology, offering an interpretable alternative or complement to black-box predictive models. We validated Histolytics through segmentation benchmarking on cervical and ovarian high-grade serous carcinoma data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.